FMC (NYSE:FMC) Q4 2025 Earnings call February 05, 2026 09:00 AM ET Company ParticipantsAndrew Sandifer - EVP and CFOCurt Brooks - Director of Investor RelationsEdlain Rodriguez - DirectorFrank Mitsch - PresidentHarris Fein - SVPPierre Brondeau - Chairman, CEO and PresidentVincent Andrews - Managing DirectorConference Call ParticipantsAleksey Yefremov - Managing Director and Equity Research AnalystJoel Jackson - Senior AnalystMatt De Yoe - Senior Equity Research AnalystMike Harrison - Managing Director and S ...

Safe Harbor Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain statements made in this presentation are forward- looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information. In some cases, you can identify these forward-looking statements by such words or phrases as "outlook", "will likely result," "is confident that," "expec ...

Company reports 2025 fourth quarter and full year results, provides 2026 outlook PHILADELPHIA, Feb. 4, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) today announced its 2026 priorities and the authorization by the Board to explore strategic options. The company also reported fourth quarter and full year 2025 results and provided its 2026 outlook. FMC is focused on executing its 2026 operational priorities, one of which is strengthening the balance sheet by paying down $1 billion in debt through asset sal ...

1. Organic Sales, Operating EPS, Free Cash Flow, and Operating EBITDA are non-GAAP measures. See page 6 for further discussion. 2. North America is defined as U.S. and Canada. EMEA is defined as Europe, Middle East and Africa. 3. The Company does not provide the most comparable GAAP measure on a forward-looking basis. See page 7 for further discussion. 4. Not meaningful. INDIANAPOLIS, Feb. 3, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) ("Corteva" or the "Company") today reported financial results for th ...

Company Overview - FMC reported a total revenue of $3.61 billion and a net income of -$531.8 million for the trailing twelve months (TTM) [5] - The company's dividend yield stands at 11.4%, with the share price as of January 22 being $16.02 [5] Recent Transaction - On January 22, tru Independence sold all 152,855 shares of FMC, resulting in a complete exit from the position, with a decrease in position value of $5.14 million [2][3][7] - FMC previously represented 1.3% of tru Independence's assets under management (AUM) [4][7] Performance Analysis - FMC's share price has decreased by 69.0% over the past year, significantly underperforming the S&P 500, which gained approximately 14% in the same period [4] - The company's third-quarter results showed a 49% year-over-year revenue decline, primarily due to the India business being held for sale, while adjusted EBITDA increased by 17% to $236 million due to cost controls [11] Strategic Focus - FMC is focusing on cost management by exiting high-cost manufacturing and resizing operations in Asia following the divestiture of its India business [12] - The company aims to prioritize balance sheet repair over income, as indicated by a dividend cut to $0.08 per share and a free cash flow outlook that is expected to hover around breakeven [12] Market Position - FMC specializes in crop protection chemicals and agricultural inputs, serving commercial farmers and agricultural businesses globally [9][10] - The company combines a diverse product portfolio with a broad geographic reach, focusing on research-driven innovation and strategic distribution to enhance crop yields and promote sustainable farming practices [10]

Core Insights - Corteva Agriscience has launched Telbek™ PRO, an innovative fungicide designed to provide unprecedented protection against Fusarium head blight and late-season leaf diseases for Canadian wheat growers [1][3] Product Details - Telbek™ PRO utilizes Adavelt™ active and features dual modes of action, Group 3 and Group 21, which help delay resistance development while effectively controlling Fusarium head blight and other diseases such as Septoria, leaf and stripe rust, tan spot, and glume blotch [2] - Early field trials indicate that Telbek™ PRO enhances yield stability and results in cleaner grain, marking a significant advancement in fungicide technology for Canadian cereal growers [3] Market Availability - Telbek™ PRO is now available through Corteva representatives across Canada, ready for the 2026 planting season [4] Company Overview - Corteva, Inc. is a global pure-play agriculture company focused on delivering innovative solutions to address pressing agricultural challenges, with a diverse mix of seed, crop protection, and digital products [4]

Core Insights - Corteva Inc. has entered a multi-million-dollar joint venture with Hexagon Bio to develop new crop protection solutions inspired by nature [1][2] - The partnership aims to combine Corteva's billion-dollar nature-inspired crop protection franchises with Hexagon Bio's natural product discovery platform, utilizing microbial genetics, AI, chemistry, and synthetic biology [2] - The collaboration is expected to enhance Corteva's crop protection innovation and meet the growing demand for sustainable agricultural solutions [3] Company Overview - Corteva, Inc. is a global pure-play agriculture company that offers innovative seed, crop protection products, and digital solutions to enhance productivity and sustainability in farming [4] - The company's innovations include nitrogen stabilizers, phosphorus-unlocking microbes, and nutrient-guidance platforms, which help improve yields and soil health while reducing fertilizer use [4] Market Analysis - Citi analyst Patrick Cunningham has reaffirmed a Hold rating on Corteva with a price target of $70, while Jefferies has reiterated a Buy rating with a price target of $85 [3] - The positive outlook from analysts follows the European Union's provisional agreement on new genomic techniques, which is expected to accelerate product launches significantly [3]

Core Insights - ADAMA Ltd. and BASF have entered a strategic co-development and commercialization agreement for the fungicide active ingredient Gilboa, aimed at providing new disease management solutions for European cereal growers [1][2][3] Group 1: Partnership Details - The collaboration will leverage ADAMA's innovation and formulation expertise alongside BASF's development capabilities and market access, ensuring faster delivery of next-generation solutions to farmers [2][5] - Each company will independently manage its own concepts, pricing, sales, and market strategies [2] Group 2: Product Development and Launch Timeline - Pending product registration approvals, Gilboa-based formulations for wheat are expected to launch in Great Britain in 2027, followed by broader European launches in 2029 [5] Group 3: Market Context and Need - European farmers are facing increasing regulatory pressures and the phase-out of existing active ingredients, creating a demand for effective and reliable crop protection tools [3] - Gilboa offers a novel mode of action for cereals, classified under FRAC Group 32, and is designed to provide broad-spectrum, long-lasting disease control solutions [3] Group 4: Company Profiles - ADAMA Ltd. is recognized as a global leader in crop protection, focusing on innovative and sustainable solutions to address challenges faced by farmers [6] - BASF Agricultural Solutions emphasizes sustainability and invests significantly in R&D, with a reported sales figure of €9.8 billion in 2024 [8]

Core Insights - In uncertain economic times, dividend-paying stocks are considered a safer investment option due to their potential for consistent payouts regardless of market fluctuations [1][2] Company Summaries UnitedHealth Group - UnitedHealth Group's share price has decreased by 36% year-to-date, primarily due to a Department of Justice investigation for alleged Medicare fraud [3][4] - The company is viewed as "too big to fail," and its valuation may become more attractive for investors believing in its recovery [3] - The growing and aging U.S. population will continue to drive demand for healthcare services [3] - Current market capitalization is $284 billion, with a recent dividend yield of 2.73%, and total yield including share buybacks is approximately 5.75% [5][6] Bank of America - Bank of America is another holding of Berkshire Hathaway, which owns about 8% of the bank [7] - The bank has been reducing its position, possibly due to decreasing interest rates affecting profitability [7] - Despite this, Bank of America has growth drivers in brokerage accounts and wealth management services, which are less impacted by interest rates [9] - The recent dividend yield is 2.15%, with total annual payout per share increasing from $0.20 in 2015 to $1.06 recently [10] Lennar - Lennar is a major American homebuilder, benefiting from the ongoing demand for affordable housing [11] - Falling interest rates could stimulate home buying, positively impacting Lennar's business [13] - The company has a backlog of nearly 17,000 homes valued at $6.6 billion and has repurchased $507 million worth of shares [14] - Recent dividend yield stands at 1.7%, with significant shareholder value enhancement through stock buybacks [14] Vanguard International High Dividend Index ETF - The Vanguard International High Dividend Index ETF focuses on dividend-paying stocks outside the U.S., appealing to investors concerned about the domestic market [15] - The ETF has a dividend yield of 3.9% and a five-year average annual return of 14% [16] FMC - FMC, a specialist in crop protection and nutrition, has a high dividend yield of 17% but has seen a stock price drop of nearly 73% year-to-date [17][18] - The company recently cut its per-share dividend by 92%, indicating financial distress [18] - FMC's challenges are linked to its India business, which is being divested, making it a riskier investment compared to other alternatives [18]

Core Insights - Syngenta and Amoéba SA have signed a Memorandum of Understanding to develop and commercialize biocontrol solutions for the EU and UK markets, focusing on cereals and field crops [3][4] - The partnership aims to address the challenge of increasing pest resistance and provide sustainable farming solutions [3][4] - The initial focus will be on combating major wheat diseases, specifically septoria tritici blotch and yellow rust, which significantly impact wheat yields and incur substantial economic losses [4] Company Overview - Syngenta is a global leader in agricultural innovation, committed to developing technologies that empower farmers and enhance sustainability [7] - Amoéba, founded in 2010, specializes in biocontrol applications using amoebae and aims to be a major player in microbiological risk treatment [8][9] - Amoéba's biocontrol solution, based on the amoeba Willaertia magna, received EU approval in 2025 and was awarded the Bernard Blum Gold Medal for its potential [5][9] Market Impact - The collaboration is expected to enhance the sustainability of farming practices and provide relief to farmers facing a shrinking toolbox of crop protection technologies [3][4] - In Germany, septoria tritici blotch causes yield losses of 5-50%, resulting in annual costs of €1.5 billion, while yellow rust can reduce yields by 10-70% [4] - The biocontrol market is increasingly important as farmers seek alternatives to chemical products due to rising pest resistance [9]